Autobahn Therapeutics
Team & Investors
Leadership, board of directors, and investment partners
Executives
0
Board Members
0
Investors
18
Total Funding
$214.5M
Investors
18 investors across all rounds
AV
Alexandria Venture Investments
OTHER
AV
ARCH Venture Partners
OTHER
B
Biogen
BO
Blue Owl Capital
BS
Bristol-Myers Squibb
Explore More Data
Detailed analysis for Autobahn Therapeutics
Autobahn Therapeutics Leadership & Investors
Autobahn Therapeutics is led by a team of experienced leaders. The company has attracted investment from 18 institutional and strategic investors.
Who Has Invested in Autobahn Therapeutics?
Autobahn Therapeutics has raised $214.5M from 18 investors including venture capital firms, private equity investors, and strategic partners.
Investment Opportunity
Accredited investors can access Autobahn Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.